secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001438133-22-000163
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes appoints Myoung Cha and Joao Malagueira to board
----------------------------------------------------------------

- Myoung Cha elected Class III director effective June 15, 2022; will serve on Compensation Committee.
- Cha is President & CSO at Carbon Health; previously Head of Health Strategic Initiatives at Apple.
- Joao Malagueira elected Class I director effective June 15, 2022; will serve on Audit Committee.
- Malagueira is VP for three divisions at Hologic; 25+ years experience in diabetes and medical devices.
- Board size increased from nine to ten directors; both new directors are independent under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813322000163/0001438133-22-000163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813322000163/tndm-20220615.htm
  HTML page:      https://secwatch.observer/filing/0001438133-22-000163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer